High mobility group box 1 promotes angiogenesis from bone marrow-derived endothelial progenitor cells after myocardial infarction

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 6, 2015, Pages 570-581

  Nakamura, Yuichi ^a   Suzuki, Satoshi ^a   Shimizu, Takeshi ^a   Miyata, Makiko ^a   Shishido, Tetsuro ^b   Ikeda, Kazuhiko ^a   Saitoh, Shu Ichi ^a   Kubota, Isao ^b   Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Endothelial progenitor cell; HMGB1; Myocardial infarction; VEGF

Indexed keywords

ANGIOPOIETIN; CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; HEART ENZYME; HIGH MOBILITY GROUP B1 PROTEIN; INTEGRIN; REACTIVE OXYGEN METABOLITE; STEM CELL FACTOR RECEPTOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN C; HMGB1 PROTEIN, MOUSE; MESSENGER RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; GRAVIMETRY; HEART INFARCTION; HISTOLOGY; IMMUNOFLUORESCENCE TEST; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; RNA EXTRACTION; ANIMAL; BONE MARROW; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CORONARY BLOOD VESSEL; ENZYME IMMUNOASSAY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; HEART VENTRICLE REMODELING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; BONE MARROW; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL PROGENITOR CELLS; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HEART; HMGB1 PROTEIN; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VENTRICULAR REMODELING;

EID: 84929354395     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.27235     Document Type: Article

References (36)

1. Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, Sadowski Z, Golba KS, Prior DL, Rouleau JL, Bonow RO: Navigating the crossroads of coronary artery disease and heart failure. Circulation, 2006; 114: 1202-1213.
2. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature, 2000; 407: 249-257.
3. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow- derived endothelial progenitor cells. EMBO J, 1999; 18: 3964-3972.
4. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E, Kosaki A, Shintani S, Murohara T, Imaizumi T, Iwasaka T: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation, 2001; 104: 1046-1052.
5. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, Weissman NJ, Leon MB, Epstein SE, Kornowski R: Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol, 2001; 37: 1726-1732.
6. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest, 2001; 107: 1395-1402.
7. Stros M: HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta, 2010; 1799: 101-113.
8. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ: HMGB1 as a DNA- binding cytokine. J Leukoc Biol, 2002; 72: 1084-1091.
9. Goodwin GH, Sanders C, Johns EW: A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem, 1973; 38: 14-19.
10. Bianchi ME, Beltrame M: Upwardly mobile proteins. The role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep, 2000; 1: 109-114.
11. Calogero S, Grassi F, Aguzzi A, Voigtländer T, Ferrier P, Ferrari S, Bianchi ME: The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet, 1999; 22: 276-280.
12. Yang H, Wang H, Czura CJ, Tracey KJ: The cytokine activity of HMGB1. J Leukoc Biol, 2005; 78: 1-8.
13. Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 2002; 418: 191-195.
14. Yanai H, Ban T, Taniguchi T: High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol, 2012; 33: 633-640.
15. Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HJ: High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. J Immunol, 2006; 177: 8701-8707.
16. Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T, Ishino M, Bilim O, Nakajima O, Kubota I: High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res, 2008; 80: 40-46.
17. Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G, Leoni O, Palumbo R, Battistini L, Rastaldo R, Müller S, Pompilio G, Anversa P, Bianchi ME, Capogrossi MC: Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit- cell proliferation and differentiation. Circ Res, 2005; 97: 73-83.
18. Yajima N, Takahashi M, Morimoto H, Shiba Y, Takahashi Y, Masumoto J, Ise H, Sagara J, Nakayama J, Taniguchi S, Ikeda U: Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice. Circulation, 2008; 117: 3079-3087.
19. Takeishi Y, Huang Q, Abe J, Glassman M, Che W, Lee JD, Kawakatsu H, Lawrence EG, Hoit BD, Berk BC, Walsh RA: Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. J Mol Cell Cardiol, 1999; 33: 1637-1648.
20. Morrison SJ, Uchida N, Weissman IL: The biology of hematopoietic stem cells. Rev Cell Dev Biol, 1995; 11: 35-71.
21. Breier G, Breviario F, Caveda L, Berthier R, Schnürch H, Gotsch U, Vestweber D, Risau W, Dejana E: Molecular cloning and expression of murine vascular endothelialcadherin in early stage development of cardiovascular system. Blood, 1996; 87: 630-641.
22. Ozdogu H, Sozer O, Boga C, Kozanoglu L, Maytalman E, Guzey M: Flow cytometric evaluation of circulating endothelial cells: a new protocol for identifying endothelial cells at several stages of differentiation. Am J Hematol, 2007; 82: 706-711.
23. Takahashi H, Takeishi Y, Miyamoto T, Shishido T, Arimoto T, Konta T, Miyashita T, Ito M, Kubota I: Protein kinase C and extracellular signal regulated kinase are involved in cardiac hypertrophy of rats with progressive renal injury. Eur J Clin Invest, 2004; 34: 85-93.
24. Takeishi Y, Abe Ji, Lee JD, Kawakatsu H, Walsh RA, Berk BC: Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase-1 by ischemia/ reperfusion and oxidative stress in perfused guinea pig hearts. Circ Res, 2004; 85: 1164-1172.
25. Hirata Y, Kurobe H, Higashida M, Fukuda D, Shimabukuro M, Tanaka K, Higashikuni Y, Kitagawa T, Sata M: HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9. Atherosclerosis, 2009; 231: 227-233.
26. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol, 2005; 5: 331-342.
27. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbäurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A.: Highmobility group box-1 in ischemia-reperfusion injury of the heart. Circulation, 2008; 117: 3216-3226.
28. Biscetti F, Ghirlanda G, Flex A: Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration. Curr Vasc Pharmacol, 2011; 9: 677-681.
29. Yamada S, Maruyama I: HMGB1, a novel inflammatory cytokine. Clin Chim Acta, 2007; 375: 36-42.
30. Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, Zeiher AM, Chavakis T, Dimmeler S.: Highmobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res, 2007; 100: 204-212.
31. Rossini A, Zacheo A, Mocini D, Totta P, Facchiano A, Castoldi R, Sordini P, Pompilio G, Abeni D, Capogrossi MC, Germani A: HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol, 2008; 44: 683-693.
32. Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, Melloni E, Presta M: Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol, 2006; 176: 12-15.
33. Schlueter C, Weber H, Meyer B, Rogalla P, Röser K, Hauke S, Bullerdiek J: Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol, 2005; 166: 1259-1263.
34. Syed IS, Sanborn TA, Rosengart TK: Therapeutic angiogenesis: a biologic bypass. Cardiology, 2004; 101: 131-143.
35. Tang JM, Wang JN, Zhang L, Zheng F, Yang JY, Kong X, Guo LY, Chen L, Huang YZ, Wan Y, Chen SY: VEGF/ SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res, 2011; 91: 402-411.
36. Takahashi M: High-mobility group box 1 protein HMGB1. in ischemic heart disease: beneficial or deleterious ? Cardiovasc Res, 2008; 80: 5-6